-+ 0.00%
-+ 0.00%
-+ 0.00%

Jasper Therapeutics director Patrick J. Crutcher files initial beneficial ownership statement

PUBT·07/21/2026 00:38:39
Listen to the news
Jasper Therapeutics director Patrick J. Crutcher files initial beneficial ownership statement
  • Jasper Therapeutics director Patrick J. Crutcher reported 518,331 voting common shares in an initial Form 3 filing dated July 16, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-079762), on July 20, 2026, and is solely responsible for the information contained therein.